retatrutide clinical trial results weight loss VisualAbstract: reduces body by 17.5% in patients with obesity retatrutide clinical trials results weight

[1] [5] Ensure you recognise hypoglycaemia symptoms (tremor, sweating, confusion, palpitations) Gallbladder problems : Report symptoms such as right upper abdominal pain, fever, or jaundice Diabetic retinopathy complications : Patients with pre-existing retinopathy should have regular eye examinations Important safety warnings: Pregnancy and breastfeeding : GLP-1 receptor agonists are not recommended during pregnancy or breastfeeding

Severe pelvic pain is a common symptom

In animal models of HF, GLP-1R agonists increase myocardial glucose uptake [62], stroke volume and LVEF, accompanied by decreasing LVEDP and systemic vascular resistance [63]

These products are not FDA-approved to diagnose, treat, cure, or prevent any disease

Approximately 20% of patients will not respond to LDN